Dietary supplement regimens may save hundreds of millions of dollars – and in some cases billions – of healthcare savings by reducing the number of disease-associated medical events, says a new report, but what do those numbers look like?
Dietary supplement regimens may reduce the number of disease-associated medical events, representing the potential for hundreds of millions of dollars – and in some cases billions – of savings, according to a new report by Frost & Sullivan and commissioned by the Council for Responsible Nutrition (CRN) Foundation.
Supplemental resveratrol should be considered as an adjunct to standard anti-diabetic agents in the treatment of type 2 diabetes, according to two studies conducted at the University of Medical Sciences in Iran and JSS University in India.
Formulating functional foods with extracts from the baobab fruit may help manage blood sugar levels, says a new study.
Metagenics, a prominent California-based dietary supplement manufacturer that specializes in medical foods and supplements sold through the practitioner channel, has received a warning letter in which FDA says a number of its medical foods are mislabeled and have claims that make them unapproved new drugs. The action signifies an FDA push toward reigning in the category, an expert said.
A new-onset type 2 diabetic who developed diarrhea after being prescribed the drug Metformin resumed regular bowel movements, lost weight and experienced a dramatic reduction in fasting blood sugar after taking a novel ‘cobiotic’ ingredient, according to a case study published in Beneficial Microbes.
Supplementation with the amino acid arginine could help to improve glucose metabolism by as much as 40%, according to new research in mice.
Formulators of products for blood sugar management have a new option, as HP Ingredients announces it is the new exclusive North American sales and marketing agent for Delphinol, a purified, concentrated standardized extract of Maqui berry (Aristotelia chilensis).
Daily ingestion of a mulberry leaf extract may lower blood sugar spikes after eating and help reduce the risk of diabetes, suggests data from a randomized clinical trial with 50 healthy people.
Vinegar (acetic acid) should be ‘purposefully’ integrated into more food matrices, say the researchers behind a new study which reports the potential blood sugar management potential of a vinegar beverage.
FDA may have opened a disease claims door for some dietary supplements when it shut another via its recently issued revised draft guidance on medical foods. That’s the contention of Peter Arhangelsky, an attorney with the law firm Emord & Associates.
A study funded by Abbott Nutrition has found that providing oral nutritional supplements to patients was associated with significant reductions in length of stay and hospitalization cost. Additionally, the 30-day readmission risk was significantly reduced for patients with at least one known subsequent readmission.
A herbal blend based on sesame seed lignan extracts can help reduce blood glucose levels among a growing proportion of the population classed as pre-diabetic, according to Indian researchers.
There is a distinct link between the composition of our gut bacteria and incidence of obesity related conditions including heart disease and diabetes, according to new data from the MetaHIT project.
Supplementation with cinnamon may lower blood pressure in pre-diabetic and diabetic people, but it’s too early to make recommendations, says a new meta-analysis.
The Amercan Botanical Council has announced that Vitatech Nutritional Sciences, a California-based vitamin and supplement formulation company, has adopted cinnamon (Cinnamomum verum) through ABC's Adopt-an-Herb Program.
FDA’s recently updated draft guidance on medical foods specifically excluded diabetes as a condition for which a medical food can be formulated and marketed. As there are a number of such foods on the market, this change has been greeted with some consternation on the part of observers of the sector.
Given that one in three American adults is expected to develop type 2 diabetes by 2050, foods and supplements targeting pre-diabetics and type 2 diabetics would appear to have enormous potential. So why isn’t the ‘healthy blood glucose’ market exploding?
A firm co-founded by Whole Foods Market chairman John Elstrott is in talks with top consumer healthcare firms about developing medical foods containing a novel ingredient claimed to improve blood glucose control and metabolic function in pre-diabetics and type 2 diabetics.
Once used for enhancing the diets of Russian astronauts, the chokeberry (Aronia melanocarpa) could have a stellar future, with the US’ leading supplier predicting extracts and concentrates could one day rival the cranberry market.